AI assistant
INSMED Inc — Director's Dealing 2014
Jun 4, 2014
30150_dirs_2014-06-04_d471e01d-fac1-4ac0-8797-d33f025327a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: INSMED INC (INSM)
CIK: 0001104506
Period of Report: 2014-06-02
Reporting Person: Schaeffer Orlov S Nicole (SVP, HR & Corp. Svcs.)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $6.96 | 2023-01-02 | Common Stock (85000) | Direct | |
| Stock Option | $12.44 | 2023-05-23 | Common Stock (40000) | Direct | |
| Stock Option | $12.44 | 2023-05-23 | Common Stock (25000) | Direct | |
| Stock Option | $20.49 | 2024-01-10 | Common Stock (27500) | Direct |
Footnotes
F1: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on the sixth month anniversary of the first anniversary date and each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
F2: Stock options granted under the Company's 2013 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on the sixth month anniversary of the first anniversary date and each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
F3: These options shall become exercisable in two equal installments upon the achievement of certain performance criteria.